Physician profile
William T Long
NPI 1023067055
$2,838,551.47
in general payments reported to CMS, 2019-2025
8 companies · $2,523 in 2025
The $2,523 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537K · 2020: $512K · 2021: $564K · 2022: $582K · 2023: $638K · 2024: $2,537 · 2025: $2,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $637K · Consulting Fee: $2,875 · Food and Beverage: $1,563 · Travel and Lodging: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $637,350.98 |
| Consulting Fee | $2,875.00 |
| Food and Beverage | $1,563.32 |
| Travel and Lodging | $1,126.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,821,505.23 | 2019-2023 | G7 |
| Total Joint Orthopedics, INC. | $11,172.58 | 2019-2025 | |
| Smith+Nephew, INC. | $4,312.80 | 2019-2024 | Legion, Real Intelligence, Redapt |
| Stryker Corporation | $1,394.11 | 2021-2025 | Mako, Profyle, Gamma |
| Advanced Orthopaedic Solutions, INC. | $103.44 | 2019 | |
| Collegium Pharmaceutical, INC. | $32.22 | 2025 | Jornay Pm |
| Solventum Corporation | $16.38 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Convatec INC. | $14.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.